BML Inc
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

BML Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
BML Inc
TSE:4694
Other Items
¥819m
CAGR 3-Years
57%
CAGR 5-Years
54%
CAGR 10-Years
N/A
E
Elan Corp
TSE:6099
Other Items
-¥2.2B
CAGR 3-Years
-101%
CAGR 5-Years
-32%
CAGR 10-Years
-76%
Solasto Corp
TSE:6197
Other Items
-¥152m
CAGR 3-Years
68%
CAGR 5-Years
52%
CAGR 10-Years
N/A
H.U. Group Holdings Inc
TSE:4544
Other Items
¥11.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
France Bed Holdings Co Ltd
TSE:7840
Other Items
¥2.5B
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
15%
Charm Care Corp
TSE:6062
Other Items
-¥12m
CAGR 3-Years
N/A
CAGR 5-Years
61%
CAGR 10-Years
33%
No Stocks Found

BML Inc
Glance View

Market Cap
162B JPY
Industry
Health Care

BML, Inc. engages in the clinical and medical laboratory testing services for hospitals and clinics. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 4,178 full-time employees. The company went IPO on 2001-04-25. The Testing segment engages in the commissioned work of clinical testing. The Medical Information Systems segment is engaged in the manufacturing and sales of system equipment for medical institutions, as well as provision of medical information service.

Intrinsic Value
3 259.98 JPY
Overvaluation 18%
Intrinsic Value
Price ¥3 975

See Also

What is BML Inc's Other Items?
Other Items
819m JPY

Based on the financial report for Dec 31, 2025, BML Inc's Other Items amounts to 819m JPY.

What is BML Inc's Other Items growth rate?
Other Items CAGR 5Y
54%

The average annual Other Items growth rates for BML Inc have been 57% over the past three years , 54% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett